Targeting Glioblastoma Stem Cells: Cell Surface Markers

被引:0
|
作者
He, J. [1 ]
Liu, Y. [2 ]
Lubman, D. M. [1 ]
机构
[1] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA
[2] SRI Int, Harrisonburg, VA 22802 USA
基金
美国国家卫生研究院;
关键词
Glioblastoma stem cell; cell surface markers; therapeutic target; proteomics; HUMAN HEMATOPOIETIC STEM; TUMOR-INITIATING CELLS; PROTEOMIC ANALYSIS; PLASMA-MEMBRANE; NERVOUS-SYSTEM; SELF-RENEWAL; QUANTITATIVE PROTEOMICS; CANCER; GLIOMA; IDENTIFICATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Glioblastoma multiforme (GBM) is the most common primary brain tumor and among the most lethal cancers. There is increasing evidence that cancer stem cells within GBMs, which are often referred to as glioblastoma stem cells (GSCs), play a critical role in tumor initiation and maintenance. Identification of novel markers for GSCs will lead to better targeting of GSCs which could have tremendous impact on treatment of GBMs. Cell surface markers are particularly suitable as therapeutic targets. Although several promising cell surface markers have successfully been used for enrichment of GSCs, their functional roles in maintenance of GSC properties as well as in GBM formation and development remain to be characterized. In this review, we primarily summarize recent advances in identification of GSC markers, with a particular focus on cell surface markers.
引用
收藏
页码:6050 / 6055
页数:6
相关论文
共 50 条
  • [41] Attempts to develop nano-targeting of glioblastoma stem cells
    Jovcevska, I.
    Samec, N.
    Zottel, A.
    Mlakar, J.
    Porcnik, A.
    Muyldermans, S.
    Myers, M. P.
    Eyer, J.
    Turnsek, T. Lah
    Komel, R.
    [J]. FEBS OPEN BIO, 2021, 11 : 268 - 268
  • [42] Advances in histone deacetylase inhibitors in targeting glioblastoma stem cells
    R. Gajendra Reddy
    Unis Ahmad Bhat
    Sumana Chakravarty
    Arvind Kumar
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 86 : 165 - 179
  • [43] Repurposing Disulfiram for Targeting of Glioblastoma Stem Cells: An In Vitro Study
    Zirjacks, Lisa
    Stransky, Nicolai
    Klumpp, Lukas
    Prause, Lukas
    Eckert, Franziska
    Zips, Daniel
    Schleicher, Sabine
    Handgretinger, Rupert
    Huber, Stephan M.
    Ganser, Katrin
    [J]. BIOMOLECULES, 2021, 11 (11)
  • [44] Targeting glioblastoma stem cells: The first step of photodynamic therapy
    Rodriguez Aguilar, Lechner
    Laura Vilchez, Maria
    Milla Sanabria, Laura N.
    [J]. PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 36
  • [45] Targeting Glioblastoma Stem Cells with Oncolytic HSV and PARP Inhibitors
    Ning, Jianfang
    Wakimoto, Hiroaki
    Martuza, Robert L.
    Rabkin, Samuel D.
    [J]. MOLECULAR THERAPY, 2014, 22 : S68 - S68
  • [46] Targeting Rad51 to radiosensitise glioblastoma stem cells
    King, H.
    Short, S. C.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S189 - S190
  • [47] Targeting Nuclear Pore Complex to Radiosensitize Glioblastoma Stem Cells
    Rich, Jeremy
    Yang, Kailin
    Ci, Shusheng
    Zhang, Junxia
    Lu, Chenfei
    Zhang, Qian
    Wu, Qiulian
    Hu, Lang
    Gao, Jiancheng
    Li, Daqi
    Shan, Danyang
    Li, Yangqing
    Li, Lu
    Zhao, Linjie
    Agnihotri, Sameer
    Qian, Xu
    Shi, Yu
    Zhang, Nu
    You, Yongping
    Wang, Xiuxing
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (09): : S21 - S21
  • [48] Squelching glioblastoma stem cells by targeting REST for proteasomal degradation
    Zhang, Peisu
    Lathia, Justin D.
    Flavahan, William A.
    Riche, Jeremy N.
    Mattson, Mark P.
    [J]. TRENDS IN NEUROSCIENCES, 2009, 32 (11) : 559 - 565
  • [49] Novel Therapeutics Against Breast Cancer Stem Cells by Targeting Surface Markers and Signaling Pathways
    Das, Plabon K.
    Rakib, Md. A.
    Khanam, Jahan A.
    Pillai, Suja
    Islam, Farhadul
    [J]. CURRENT STEM CELL RESEARCH & THERAPY, 2019, 14 (08) : 669 - 682
  • [50] Evaluation of stem cell markers and different stemness genes in glioblastoma cell lines
    Dreher, L.
    Perrech, M.
    Roehn, G.
    Goldbrunner, R.
    Saric, T.
    Timmer, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 119 - 119